Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023)

dc.contributor.authorKaracin, Cengiz
dc.contributor.authorOksuzoglu, Berna
dc.contributor.authorDemirci, Ayse
dc.contributor.authorKeskinkilic, Merve
dc.contributor.authorBaytemur, Naziyet Kose
dc.contributor.authorYilmaz, Funda
dc.contributor.authorSelvi, Oguzhan
dc.date.accessioned2024-02-23T14:27:18Z
dc.date.available2024-02-23T14:27:18Z
dc.date.issued2023
dc.departmentNEÜen_US
dc.description.abstract[Abstract Not Availabe]en_US
dc.identifier.doi10.1186/s12885-023-10662-3
dc.identifier.issn1471-2407
dc.identifier.issue1en_US
dc.identifier.pmid36849943en_US
dc.identifier.scopus2-s2.0-85148970683en_US
dc.identifier.urihttps://doi.org/10.1186/s12885-023-10662-3
dc.identifier.urihttps://hdl.handle.net/20.500.12452/14538
dc.identifier.volume23en_US
dc.identifier.wosWOS:000941147400001en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherBmcen_US
dc.relation.ispartofBmc Canceren_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[Keyword Not Available]en_US
dc.titleEfficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023)en_US
dc.typeCorrectionen_US

Dosyalar